Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts

✍ Scribed by Mamoru Nukatsuka; Hitoshi Saito; Fumio Nakagawa; Masaaki Abe; Junji Uchida; Jiro Shibata; Ken-ichi Matsuo; Shinzaburo Noguchi; Mamoru Kiniwa

• Publisher: Springer US
• Year: 2010
• Tongue: English
• Weight: 527 KB
• Volume: 128
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-010-1141-3